Sanofi-Aventis U.S. LLC recalls Docetaxel injection concentrate, 20 mg/mL, 1 mL vial, Rx only, Winthrop U.S. a business of Sanofi-Aventis U.S. LLC., NDC
Recalled May 9, 2018 · FDA recall D-0804-2018 · Sanofi-Aventis U.S
Hazard
Superpotent drug: over-concentrated vials of Docetaxel injection concentrate 20 mg/mL may have been distributed. · FDA Class II
Units
19580 vials
Sold at
US nationwide
Description
Superpotent drug: over-concentrated vials of Docetaxel injection concentrate 20 mg/mL may have been distributed.
Product
Docetaxel injection concentrate, 20 mg/mL, 1 mL vial, Rx only, Winthrop U.S. a business of Sanofi-Aventis U.S. LLC., NDC 0955-1020-01
Manufacturer(s)
Sanofi-Aventis U.S. LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →